Artia Global Partners LP / RETAEUR
Artia Global Partners LP’s Reata Pharmaceuticals Inc Position
Does Artia Global Partners LP own Reata Pharmaceuticals Inc (RETAEUR)? Not currently — the last reported position was 40.0K shares worth $4M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q1 2023
Shares
40.0K
% of Portfolio
+1.34%
Quarters Held
1
position exited
Position History RETAEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 40.0K | $4M | +1.34% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of RETAEUR.